Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Galantamine Augmentation of Escitalopram for Treatment of Depression Associated Cognitive Impairment in Outpatients - A Randomized Single Blind Clinical Trial

NCT00423969 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT00423969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00423969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Galantamine Augmentation of Escitalopram for Treatment of Depression Associated Cognitive Impairment in Outpatients - A Randomized Single Blind Clinical Trial
Lead sponsor
Indiana University
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2003
Completion date
September 30, 2005
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression